DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Vivaglobin (Immune Globulin Subcutaneous Human) - Side Effect Reports to FDA

 
 



Index of reports > All Cases (34)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Vivaglobin (Immune Globulin Subcutaneous Human) all cases. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 34   Next >>

Possible Vivaglobin side effects in 20 year old female

Reported by a physician from United States on 2012-08-13

Patient: 20 year old female

Reactions: Haemorrhagic Cerebral Infarction, Superior Sagittal Sinus Thrombosis, Intracranial Venous Sinus Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vivaglobin

Other drugs received by patient: Ethinyl Estradiol TAB; Drospirenone (Drospirenone)



Possible Vivaglobin side effects in 20 year old female

Reported by a physician from United States on 2012-08-03

Patient: 20 year old female

Reactions: Haemorrhagic Cerebral Infarction, Headache, Hemiparesis, Paraesthesia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vivaglobin

Other drugs received by patient: Ethinyl Estradiol TAB; Drospirenone (Drospirenone)



Possible Vivaglobin side effects in 67 year old male

Reported by a individual with unspecified qualification from Canada on 2012-07-18

Patient: 67 year old male

Reactions: Respiratory Failure

Adverse event resulted in: death

Drug(s) suspected as cause:
Vivaglobin



Possible Vivaglobin side effects in female

Reported by a consumer/non-health professional from United States on 2012-06-20

Patient: female, weighing 59.0 kg (129.7 pounds)

Reactions: Drug Ineffective, Asthenia, Infusion Site Swelling, Infusion Site Pruritus, Infusion Site Erythema

Drug(s) suspected as cause:
Vivaglobin



Possible Vivaglobin side effects in female

Reported by a physician from United States on 2012-06-19

Patient: female, weighing 61.2 kg (134.7 pounds)

Reactions: Herpes Simplex Serology Positive, Transmission of AN Infectious Agent VIA A Medicinal Product

Drug(s) suspected as cause:
Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-06-07

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2011-03-29

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-11-22

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2011-01-06

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2011-01-26

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2009-11-17

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-08-03

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-07-06

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2011-02-22

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-01-18

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-05-11

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-08-31

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2009-11-17

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-03-16

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2009-12-15

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-02-16

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-09-28

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-10-26

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2010-12-21

Vivaglobin
    Dosage: (9.6 g 1x/week, stop day may 2011 subcutaneous)
    Indication: Humoral Immune Defect
    Start date: 2011-04-27

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Other drugs received by patient: Vivaglobin



Possible Vivaglobin side effects in female

Reported by a pharmacist from United States on 2012-06-11

Patient: female, weighing 61.2 kg (134.7 pounds)

Reactions: Herpes Simplex Serology Positive, Transmission of AN Infectious Agent VIA A Medicinal Product

Drug(s) suspected as cause:
Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-06-07

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-06-07

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-01-18

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-01-18

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-09-28

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-09-28

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2009-11-17

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2009-11-17

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-08-31

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-08-31

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2011-03-29

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2011-03-29

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2009-11-17

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2009-11-17

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2009-12-15

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2009-12-15

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-12-21

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-12-21

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-03-16

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-03-16

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2011-04-27

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2011-04-27

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-08-03

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-08-03

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-10-26

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-10-26

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2011-01-06

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2011-01-06

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2011-02-22

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2011-02-22

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-02-16

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-02-16

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-05-11

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-05-11

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-07-06

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-07-06

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2010-11-22

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2010-11-22

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Hypogammaglobulinaemia
    Start date: 2011-01-26

Vivaglobin
    Dosage: 9.6 g 2x/week, stop day may 2011 subcutaneous, (9.6 g 2x/week, stop day may 2011 subcutaneous
    Indication: Immunodeficiency Common Variable
    Start date: 2011-01-26

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin



Possible Vivaglobin side effects in 70 year old female

Reported by a health professional (non-physician/pharmacist) from Sweden on 2012-06-06

Patient: 70 year old female

Reactions: Dysphagia, Chills, Bone Pain, Pain, Headache, Eye Pain, Off Label Use, Syncope, Fatigue, Arthralgia, Diarrhoea Haemorrhagic, Vertigo, Disturbance in Attention, Vision Blurred, Ear Pain

Drug(s) suspected as cause:
Vivaglobin



Possible Vivaglobin side effects in 58 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-06-01

Patient: 58 year old female

Reactions: Back Pain, Burning Sensation, Dyspnoea, Product Contamination Microbial, Hypersensitivity

Drug(s) suspected as cause:
Vivaglobin

Vivaglobin
    Dosage: 30 ml, at rate of 1ml/minute
    Indication: Immunodeficiency
    Start date: 2011-05-25

Vivaglobin
    Dosage: 30 ml, at rate of 1ml/minute
    Indication: Hypogammaglobulinaemia
    Start date: 2011-05-25

Vivaglobin
    Dosage: 30 ml, at rate of 1ml/minute
    Indication: Immunodeficiency
    Start date: 2012-03-03
    End date: 2012-03-03

Vivaglobin
    Dosage: 30 ml, at rate of 1ml/minute
    Indication: Hypogammaglobulinaemia
    Start date: 2012-03-03
    End date: 2012-03-03

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Other drugs received by patient: APO-Hydroxyquine (Hydroxychloroquine Sulfate); Calcium Carbonate; Vitamin D



Possible Vivaglobin side effects in 26 year old male

Reported by a individual with unspecified qualification from Belgium on 2012-05-07

Patient: 26 year old male

Reactions: Pulmonary Vasculitis, Cutaneous Vasculitis, Vasculitis Cerebral

Adverse event resulted in: death

Drug(s) suspected as cause:
Vivaglobin



Possible Vivaglobin side effects in female

Reported by a pharmacist from United States on 2012-04-23

Patient: female, weighing 61.2 kg (134.7 pounds)

Reactions: Herpes Simplex Serology Positive, Transmission of AN Infectious Agent VIA A Medicinal Product

Drug(s) suspected as cause:
Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2009-11-17
    End date: 2011-05-01

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2009-11-17
    End date: 2011-05-01

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-10-26

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-10-26

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-02-16

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-02-16

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2011-01-06

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2011-01-06

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-03-16

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-03-16

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-05-11

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-05-11

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-08-31

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-08-31

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2011-04-27

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2011-04-27

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2009-12-15

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2009-12-15

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-06-07

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-06-07

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-11-22

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-11-22

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2011-03-29

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2011-03-29

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-01-18

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-01-18

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-07-06

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-07-06

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2011-01-26

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2011-01-26

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2011-02-22

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2011-02-22

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-09-28

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-09-28

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-12-21

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-12-21

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2009-11-17

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2009-11-17

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    Start date: 2010-08-03

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-08-03

Vivaglobin

Vivaglobin

Vivaglobin



Possible Vivaglobin side effects in 26 year old male

Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-04-16

Patient: 26 year old male

Reactions: Cutaneous Vasculitis, Pulmonary Vasculitis, Vasculitis Cerebral

Adverse event resulted in: death

Drug(s) suspected as cause:
Vivaglobin



Possible Vivaglobin side effects in female

Reported by a pharmacist from United States on 2012-04-05

Patient: female

Reactions: Simplex Virus Test Positive, Transmission of AN Infectious Agent VIA A Medicinal Product

Drug(s) suspected as cause:
Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Hypogammaglobulinaemia
    End date: 2011-05-01

Vivaglobin
    Dosage: (9.6 g 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    End date: 2011-05-01



Possible Vivaglobin side effects in 58 year old female

Reported by a individual with unspecified qualification from Canada on 2012-04-02

Patient: 58 year old female

Reactions: Burning Sensation, Back Pain, Product Contamination Microbial, Dyspnoea, Hypersensitivity, Injection Site Pain

Drug(s) suspected as cause:
Vivaglobin
    Dosage: 30 ml, at rate of 1ml/minute, subcutaneous
    Indication: Immunodeficiency
    Start date: 2012-03-03
    End date: 2012-03-03

Vivaglobin

Vivaglobin
    Indication: Hypogammaglobulinaemia

Vivaglobin
    Indication: Immunodeficiency

Vivaglobin
    Indication: Immunodeficiency
    Start date: 2011-05-25

Vivaglobin
    Indication: Hypogammaglobulinaemia
    Start date: 2011-05-25

Vivaglobin
    Indication: Immunodeficiency

Vivaglobin
    Indication: Hypogammaglobulinaemia

Vivaglobin
    Indication: Immunodeficiency

Vivaglobin
    Indication: Hypogammaglobulinaemia

Other drugs received by patient: APO-Hydroxyquine (Hydroxychloroquine Sulfate); Vitamin D; Calcium



Possible Vivaglobin side effects in 51 year old male

Reported by a physician from France on 2012-03-30

Patient: 51 year old male

Reactions: Diabetes Mellitus, Anaemia, Cytomegalovirus Infection, Toxicity To Various Agents, Thrombocytopenia, Leukopenia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
ACT HIB (Haemophilus B Conjugate Vaccine)
    Indication: Immunisation
    Start date: 2011-09-26
    End date: 2011-09-26

ACT HIB (Haemophilus B Conjugate Vaccine)
    Indication: Immunisation
    Start date: 2011-11-08
    End date: 2011-11-08

Ganciclovir
    Dosage: 250 mg;qd;po
    Administration route: Oral
    Indication: Cytomegalovirus Viraemia
    Start date: 2011-08-12
    End date: 2011-08-26

Ganciclovir
    Dosage: 250 mg;qd;po
    Administration route: Oral
    Indication: Cytomegalovirus Viraemia
    Start date: 2011-07-15
    End date: 2011-07-20

Noxafil
    Dosage: 200 mg;tid
    Indication: Oral Lichen Planus
    Start date: 2011-07-15
    End date: 2011-09-26

Prednisone
    Dosage: 30 mg;bid
    Indication: Acute Graft Versus Host Disease
    Start date: 2011-07-15
    End date: 2011-09-26

Vivaglobin
    Dosage: 1 df;qw;iv
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-10-25

Other drugs received by patient: Foscavir



Possible Vivaglobin side effects in 51 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-27

Patient: 51 year old male

Reactions: Polydipsia, Incorrect Route of Drug Administration, Graft Versus Host Disease, Cytomegalovirus Test Positive, Diabetes Mellitus, Polyuria, Off Label Use, Bone Marrow Disorder, Haemoglobin Decreased, Thrombocytopenia, Leukopenia, White Blood Cell Count Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
ACT HIB (Haemophilus B Conjugate Vaccine)
    Indication: Immunisation
    Start date: 2011-09-26
    End date: 2011-09-26

ACT HIB (Haemophilus B Conjugate Vaccine)
    Indication: Immunisation
    Start date: 2011-11-08
    End date: 2011-11-08

Noxafil
    Start date: 2011-07-15
    End date: 2011-09-26

Vivaglobin
    Dosage: 6.4 g 1x/week, 160mg/ml every 7 days intravenous (not otherwise specified)
    Indication: Chronic Lymphocytic Leukaemia
    Start date: 2011-10-25

Other drugs received by patient: Foscavir; Prednisone TAB; Ganciclovir



Possible Vivaglobin side effects in 15 year old male

Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-03-08

Patient: 15 year old male

Reactions: Pain, Sensory Loss, Headache

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vivaglobin

Other drugs received by patient: Aerius (Desloratadine) Indication FOR USE WAS Allergy



Possible Vivaglobin side effects in 30 month old male

Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-03-06

Patient: 30 month old male

Reactions: Abasia, Areflexia

Drug(s) suspected as cause:
Vivaglobin



Possible Vivaglobin side effects in female

Reported by a physician from United States on 2012-03-05

Patient: female, weighing 59.9 kg (131.7 pounds)

Reactions: Weight Increased, Dysphonia, Deep Vein Thrombosis

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vivaglobin

Other drugs received by patient: Levaquin; Zantac; Spiriva; Symbicort



Possible Vivaglobin side effects in 51 year old male

Reported by a health professional (non-physician/pharmacist) from France on 2012-03-05

Patient: 51 year old male

Reactions: Incorrect Route of Drug Administration, White Blood Cell Count Decreased, Polydipsia, Graft Versus Host Disease, Cytomegalovirus Test Positive, Polyuria, Haemoglobin Decreased, Bone Marrow Disorder, Off Label Use, Thrombocytopenia, White Blood Cell Count Increased

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vivaglobin

Other drugs received by patient: Ganciclovir; Voriconazole; Prednisone TAB; ACT HIB (Haemophilus B Conjugate Vaccine)



Possible Vivaglobin side effects in 59 year old female

Reported by a health professional (non-physician/pharmacist) from Canada on 2012-02-22

Patient: 59 year old female

Reactions: Staphylococcal Infection, Haematoma Infection, Infusion Site Swelling, Infusion Site Rash

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vivaglobin

Other drugs received by patient: Fluoxetine; Ramipril; Levothyroxine Sodium; Albuterol Sulfate; Furosemide (Furosemide); Omega-3 / 01168901 / (Omega-3 Triglycerides); Ezetimibe; Tylenol with Codeine (Panadeine CO); Atorvastatin; Gliclazide (Gliclazide); Lorazepam; Aspirin; Daily Multivitamin (Daily Multivitamin); Symbicort; Beres C-Vitamin (Ascorbic Acid); Calcium with Vitamin D (Calcium with Vitamin D); Ferrous Fumarate



Possible Vivaglobin side effects in 29 year old female

Reported by a physician from United States on 2012-02-07

Patient: 29 year old female, weighing 72.6 kg (159.7 pounds)

Reactions: Pancytopenia

Drug(s) suspected as cause:
Vivaglobin
    Dosage: (11.2 g 1x/week, infused 70ml over 1-2 hours subcutaneous), ()
    Indication: Immunodeficiency Common Variable
    Start date: 2011-03-13

Vivaglobin
    Dosage: (11.2 g 1x/week, infused 70ml over 1-2 hours subcutaneous), ()
    Indication: Immunodeficiency Common Variable
    Start date: 2010-07-07

Other drugs received by patient: Oracea; Aczone (Dapsone); Desonate (Desonide)



Possible Vivaglobin side effects in 76 year old female

Reported by a pharmacist from United States on 2012-02-07

Patient: 76 year old female, weighing 63.5 kg (139.7 pounds)

Reactions: Headache

Adverse event resulted in: disablity

Drug(s) suspected as cause:
Vivaglobin
    Dosage: see image
    Indication: Immunodeficiency Common Variable
    Start date: 2009-01-01

Vivaglobin
    Dosage: see image
    Indication: Immunodeficiency Common Variable
    Start date: 2009-12-01

Vivaglobin
    Dosage: see image
    Indication: Immunodeficiency Common Variable
    Start date: 2011-02-04

Other drugs received by patient: Astelin (Diprophylline); Centrum Silver (Centrum Silver); Synthroid; Estradiol; Singulair; Xyzal; Clarinex; Reglan; Citracal D (Citracal + D); Metoclopramide; Advair Diskus 100 / 50



Possible Vivaglobin side effects in 70 year old female

Reported by a health professional (non-physician/pharmacist) from Sweden on 2012-02-07

Patient: 70 year old female

Reactions: Off Label Use, Fatigue, Arthralgia, Bone Pain, Vision Blurred, Vertigo, Ear Pain, Headache, Eye Pain

Drug(s) suspected as cause:
Vivaglobin



Possible Vivaglobin side effects in 47 year old female

Reported by a pharmacist from United States on 2012-02-07

Patient: 47 year old female, weighing 61.2 kg (134.7 pounds)

Reactions: Liver Function Test Abnormal, Hepatic Steatosis

Drug(s) suspected as cause:
Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin
    Dosage: see image
    Indication: Immunodeficiency Common Variable
    Start date: 2010-01-01
    End date: 2010-11-01

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin



Possible Vivaglobin side effects in 61 year old female

Reported by a pharmacist from United States on 2012-02-07

Patient: 61 year old female, weighing 104.3 kg (229.5 pounds)

Reactions: Thrombosis, Infusion Site Swelling, Infusion Site Erythema

Drug(s) suspected as cause:
Vivaglobin
    Dosage: see image
    Indication: Immunodeficiency Common Variable
    Start date: 2009-05-01

Vivaglobin

Vivaglobin

Vivaglobin

Other drugs received by patient: Nexium; Ambien; Coumadin; Crestor; Ipratropium Bromide; Albuterol; Lexapro; Tricor; Xanax; Theocap (Theophylline); Coreg; Reglan; Singulair; Prednisone TAB; Advair Diskus 100 / 50



Possible Vivaglobin side effects in 57 year old female

Reported by a consumer/non-health professional from United States on 2012-02-07

Patient: 57 year old female

Reactions: Migraine, Urticaria, Musculoskeletal Stiffness, Meningitis Aseptic

Drug(s) suspected as cause:
Vivaglobin



Possible Vivaglobin side effects in female

Reported by a pharmacist from United States on 2012-02-07

Patient: female, weighing 46.7 kg (102.8 pounds)

Reactions: Convulsion

Drug(s) suspected as cause:
Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin

Vivaglobin
    Dosage: see image
    Indication: Immune System Disorder
    Start date: 2010-03-01
    End date: 2011-02-01

Vivaglobin

Other drugs received by patient: Phenobarbital TAB; Urocit-K SR (Potassium Citrate); Keppra; Ovaza (Omega-3 Fatty Acids); Magnesium Oxide (Magnesium Oxide); Prilosec; Patanase 0.6% Nasal Spray (Olopatadine)



Possible Vivaglobin side effects in female

Reported by a physician from United States on 2012-02-07

Patient: female, weighing 61.9 kg (136.2 pounds)

Reactions: Back Pain, Nausea, Photophobia, Headache, Meningitis Aseptic, Infusion Site Urticaria, Infusion Site Swelling

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vivaglobin
    Dosage: see image
    Indication: Immunodeficiency Common Variable
    Start date: 2007-02-01

Vivaglobin
    Dosage: see image
    Indication: Immunodeficiency Common Variable
    Start date: 2007-02-01

Vivaglobin
    Dosage: see image
    Indication: Immunodeficiency Common Variable
    Start date: 2007-02-01



Possible Vivaglobin side effects in female

Reported by a consumer/non-health professional from United States on 2012-02-07

Patient: female, weighing 58.1 kg (127.7 pounds)

Reactions: Migraine, Dyspnoea, Insomnia, Dehydration, Decreased Appetite

Drug(s) suspected as cause:
Vivaglobin
    Dosage: (40 ml 1x/week subcutaneous)
    Indication: Immunodeficiency Common Variable
    Start date: 2010-12-01

Vivaglobin



Possible Vivaglobin side effects in 36 year old female

Reported by a health professional (non-physician/pharmacist) from Spain on 2012-01-27

Patient: 36 year old female

Reactions: Malaise, Palpitations, Vision Blurred

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Vivaglobin



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017